Randomized, evaluator-blinded, no treatment controlled multicenter study to evaluate safety and effectiveness of GP0109 for augmentation and correction or retrusion in the chin region in Canada
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
140
Injectable gel. Chin correction and augmentation for retrusion
Galderma Research Site
Calgary, Alberta, Canada
Galderma Research Site
Vancouver, British Columbia, Canada
Galderma Research Site
Vancouver, British Columbia, Canada
Galderma Research Site
Vancouver, British Columbia, Canada
Responder rate based on the Galderma Chin Retrusion Scale as assessed live by the Blinded Evaluator
Time frame: 3 months after baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Galderma Research Site
Burlington, Ontario, Canada
Galderma Research Site
Toronto, Ontario, Canada
Galderma Research Site
Toronto, Ontario, Canada
Galderma Research Site
Woodbridge, Ontario, Canada
Galderma Research Site
Westmount, Quebec, Canada